INR 162.3
(1.98%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 56.41 Million INR | -13.36% |
2022 | 65.12 Million INR | -74.22% |
2021 | 252.58 Million INR | -19.52% |
2020 | 313.84 Million INR | 13.56% |
2019 | 276.36 Million INR | -11.35% |
2018 | 311.75 Million INR | 11.4% |
2017 | 279.84 Million INR | 103.94% |
2016 | 137.22 Million INR | 140.62% |
2015 | 57.02 Million INR | 1012.76% |
2014 | 5.12 Million INR | 271.11% |
2013 | 1.38 Million INR | -87.33% |
2012 | 10.89 Million INR | 10.28% |
2011 | 9.88 Million INR | -88.6% |
2010 | 86.66 Million INR | -26.69% |
2009 | 118.2 Million INR | -26.41% |
2008 | 160.64 Million INR | 30.05% |
2007 | 123.52 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 FY | 56.41 Million INR | -13.36% |
2023 Q2 | 42.07 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 56.41 Million INR | 0.0% |
2022 Q4 | 65.12 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 235.12 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 65.12 Million INR | -74.22% |
2021 FY | 252.58 Million INR | -19.52% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 293.8 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 252.58 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 313.84 Million INR | 13.56% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 260.24 Million INR | 0.0% |
2020 Q4 | 313.84 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 277.17 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 276.36 Million INR | 0.0% |
2019 FY | 276.36 Million INR | -11.35% |
2018 Q1 | - INR | -100.0% |
2018 FY | 311.75 Million INR | 11.4% |
2018 Q4 | 311.75 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 252.95 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 FY | 279.84 Million INR | 103.94% |
2017 Q4 | 258.02 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 237.55 Million INR | 0.0% |
2016 Q4 | 129.8 Million INR | 0.0% |
2016 FY | 137.22 Million INR | 140.62% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 81.88 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2015 Q4 | 57.02 Million INR | 0.0% |
2015 FY | 57.02 Million INR | 1012.76% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 131.52 Million INR | 0.0% |
2014 Q2 | 12.87 Million INR | 0.0% |
2014 FY | 5.12 Million INR | 271.11% |
2014 Q4 | 5.12 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 Q3 | - INR | 0.0% |
2013 FY | 1.38 Million INR | -87.33% |
2013 Q1 | - INR | -100.0% |
2013 Q2 | - INR | 0.0% |
2013 Q4 | 1.38 Million INR | 0.0% |
2012 Q2 | - INR | 0.0% |
2012 Q4 | 10.89 Million INR | 0.0% |
2012 FY | 10.89 Million INR | 10.28% |
2011 Q4 | 9.88 Million INR | 0.0% |
2011 FY | 9.88 Million INR | -88.6% |
2010 FY | 86.66 Million INR | -26.69% |
2009 FY | 118.2 Million INR | -26.41% |
2008 FY | 160.64 Million INR | 30.05% |
2007 FY | 123.52 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | 84.008% |
Amrutanjan Health Care Limited | 17.28 Million INR | -226.442% |
Sigachi Industries Limited | 1.43 Billion INR | 96.056% |
Bal Pharma Limited | 1.39 Billion INR | 95.96% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 66.057% |
Medico Remedies Limited | 80.5 Million INR | 29.918% |
Lasa Supergenerics Limited | 220.76 Million INR | 74.444% |
Venus Remedies Limited | 413.3 Million INR | 86.349% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 90.774% |
Alpa Laboratories Limited | 52.46 Million INR | -7.536% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.112% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.398% |
Aarti Drugs Limited | 5.64 Billion INR | 99.0% |
Lupin Limited | 29.21 Billion INR | 99.807% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.915% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.298% |
Windlas Biotech Limited | 36.41 Million INR | -54.955% |
Suven Life Sciences Limited | 7.09 Million INR | -694.97% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.797% |
Valiant Laboratories Limited | 767.08 Million INR | 92.645% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 98.506% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.442% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.608% |
Bliss GVS Pharma Limited | 998.4 Million INR | 94.349% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.828% |
Bajaj HealthCare Limited | 3.32 Billion INR | 98.305% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | 97.277% |
Laurus Labs Limited | 25.77 Billion INR | 99.781% |
Piramal Pharma Limited | 47.1 Billion INR | 99.88% |
Syncom Formulations (India) Limited | 724.86 Million INR | 92.217% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.86% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 98.901% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.542% |
Unichem Laboratories Limited | 2.47 Billion INR | 97.721% |
Sequent Scientific Limited | 4.87 Billion INR | 98.843% |
Novartis India Limited | 69.7 Million INR | 19.055% |
Wanbury Limited | 1.16 Billion INR | 95.157% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 91.32% |
Wockhardt Limited | 23.56 Billion INR | 99.761% |
Themis Medicare Limited | 957.92 Million INR | 94.11% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 36.899% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.846% |
Glenmark Life Sciences Limited | 171.48 Million INR | 67.099% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.718% |
Divi's Laboratories Limited | 30 Million INR | -88.063% |
NATCO Pharma Limited | 3.71 Billion INR | 98.48% |
Gufic Biosciences Limited | 3.32 Billion INR | 98.305% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 82.778% |
Ind-Swift Limited | 10.13 Billion INR | 99.444% |
Procter & Gamble Health Limited | 95.6 Million INR | 40.984% |
FDC Limited | 205.18 Million INR | 72.503% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 97.083% |
Granules India Limited | 13.15 Billion INR | 99.571% |
Medicamen Biotech Limited | 308.17 Million INR | 81.692% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.602% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -22.698% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1185.464% |
Megasoft Limited | 1.47 Billion INR | 96.163% |
ZIM Laboratories Limited | 1.08 Billion INR | 94.816% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.776% |
Neuland Laboratories Limited | 953.89 Million INR | 94.085% |
Morepen Laboratories Limited | 289.99 Million INR | 80.545% |
Hikal Limited | 8.17 Billion INR | 99.31% |
Indoco Remedies Limited | 6.71 Billion INR | 99.16% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 98.022% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 82.172% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 94.272% |
Hester Biosciences Limited | 2.44 Billion INR | 97.691% |